Safeguard Scientifics, Inc.

SFES Financial Asset Management

In the quarter to June 2026, EPS fell 121.7% and free cash flow grew 42.7%, each against the same quarter a year earlier.

0.50 0.03 +6.38%
Market cap
$7.5M
P/E
0.4×
Fwd P/E
—
Dividend yield
0.00%
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Current Ratio
10.06 5.83 4.84 11.79 17.46 4.63 10.85 1.42 0.73 5.55
Net Debt/EBITDA
5.40 3.03 1.77 4.29 3.58 1.70 4.59 (2.06) (3.98) (1.32)
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.05 1.05 0.31
ROE
16.14% (69.68%) (36.03%) (33.50%) 47.61% (45.70%) 64.68% (21.01%) (70.41%) (12.19%)
ROA
14.48% (60.84%) (32.47%) (31.10%) 43.89% (42.60%) 43.08% (9.70%) (43.39%) (9.11%)
ROIC
(50.98%) (54.53%) (33.95%) (19.55%) (17.33%) (12.51%) (8.14%) (11.59%) (7.72%) (6.09%)
Return on Tangible Assets
20.79% (175.42%) (124.96%) (72.75%) 94.60% (298.70%) 209.67% (107.03%) 828.47% (77.94%)
Free Cash Flow per Share
(0.11) (0.17) (0.20) (0.20) (0.41) (0.39) (0.97) (1.27) (1.02) (0.94)
Book value per Share
0.69 0.59 1.23 2.12 2.55 3.03 4.93 3.26 4.00 8.35
Free Cash Flow
(1.77) (2.78) (3.31) (3.26) (8.15) (8.14) (19.97) (26.03) (20.80) (19.09)
Other line items

Show all line items

Columns are period end dates